Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN-

K-Number: K830025 · 1983-03-31

Decision Date1983-03-31
Product CodeDQO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN- is the device name listed in this FDA 510(k) record. The listed applicant is Medrad/Technology For People. It received FDA 510(k) clearance on 1983-03-31 under 510(k) number K830025. The device is classified under product code DQO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN-?

DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN- is a medical device that received FDA 510(k) clearance on 1983-03-31. The listed applicant is Medrad/Technology For People. The 510(k) number is K830025.

When did DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN- receive FDA 510(k) clearance?

DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN- received FDA 510(k) clearance on 1983-03-31, under 510(k) number K830025.

Who is the listed applicant for DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN-?

The FDA 510(k) record lists Medrad/Technology For People as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN-?

The FDA product code for DIGITAL SUBTRACTION ANGIOGRAPHY CONVEN- is DQO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DQO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑